Skip to content
    Agilent Technologies logo

    Agilent Technologies

    Santa Clara, California, United StatesFounded 1999
    www.agilent.comLinkedIn
    Biotech & Life SciencesHealthcareHardware & Semiconductors

    Agilent Technologies is a global life sciences, diagnostics, and applied chemical company headquartered in Santa Clara, California. Through its corporate venture arm, Agilent Ventures, it invests in early-stage technology and life sciences start-ups, leveraging Agilent's technological resources and industry relationships to support portfolio companies.

    54% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $29.1M (across 31 rounds with reported amounts).

    Find people at Agilent Technologies on Goldilocks AI

    Portfolio

    25

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    KB

    Koh Boon Hwee

    Independent Chairman, Agilent Technologies, Inc., Managing Partner, Creence Capital Fund II (Cayman) Ltd..

    PS

    Pascal Soriot

    Executive Director and Chief Executive Officer, AstraZeneca

    MA

    Mala Anand

    Corporate Vice President, Customer Experience, Microsoft

    DM

    Dr. Mikael Dolsten

    Chief Scientific Officer and President, Worldwide Research, Development and Medical, Pfizer Inc.

    PM

    Padraig McDonnell

    President and Chief Executive Officer, Agilent

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    35 investments
    CompanyRoundAmountDate
    Biofidelity logoBiofidelitySeries A$12MJan 2026
    PreciseDx logoPreciseDxSeries B$20.7MAug 2024
    Biofidelity logoBiofidelitySeries A$24MApr 2024
    NanoCellect logoNanoCellectUnknown$86MJan 2023
    Halo Labs logoHalo LabsSeries C$6MJul 2022
    Molecular Assemblies logoMolecular AssembliesSeries B$25.8MMar 2022
    PreciseDx logoPreciseDxSeries A$10.8MJan 2022
    AArima GenomicsSeries B$7MJan 2022
    Akadeum Life Sciences logoAkadeum Life SciencesSeries B$17.5MOct 2021
    Rarecyte logoRarecyteSeries B$24MSep 2021
    MMOBILion SystemsSeries C$60MJul 2021
    CCardeaUnknown$6.5MJan 2021
    NanoCellect logoNanoCellectSeries C$15MJan 2021
    Nicoya logoNicoyaSeries A$20MJan 2021
    CCardea BioSeries A$7.5MJan 2021
    DNA Script logoDNA ScriptSeries B—Aug 2020
    Biofidelity logoBiofidelitySeries A$12MMay 2020
    Molecular Assemblies logoMolecular AssembliesSeries A$12.2MOct 2019
    Akoya Biosciences logoAkoya BiosciencesUnknown$50MJan 2019
    AAkoyaUnknown$50MJan 2019
    Mission Bio logoMission BioSeries C$70MDec 2018
    NanoCellect logoNanoCellectSeries B$10MNov 2017
    Molecular Assemblies logoMolecular AssembliesSeed$2.3MDec 2016
    Purigen logoPurigenSeries B$26.4MJan 2013
    TTelASICSeries C$35MOct 2003
    Page 1 of 2

    Top Co-Investors

    Illumina Ventures7 shared
    Berkeley Catalyst Fund5 shared
    TCA Venture Group3 shared
    Alexandria Venture Investments3 shared
    Octopus Ventures3 shared
    BlueYard Capital3 shared
    Casdin Capital3 shared
    iSelect Fund3 shared
    Telegraph Hill Partners3 shared
    The Vertical Group3 shared
    FusionX Ventures3 shared
    Anzu Partners3 shared
    MaRS IAF3 shared
    Cota Capital2 shared
    Keshif Ventures2 shared
    aMoon2 shared
    Cultivation Capital2 shared
    Hostplus2 shared
    Notion Capital2 shared
    Arbor Ventures2 shared

    Last updated: 7 October 2026